C
Cyclacel Pharmaceuticals D
D
CYCC
15.990
USD
-0.76
(-4.54%)
مغلق
حجم التداول
10,987
الربح لكل سهم
-1
العائد الربحي
-
P/E
0
حجم السوق
25,327,600
الأخبار المقالات
العنوان: Cyclacel Pharmaceuticals Inc
القطاع: Healthcare
الصناعة: Biotechnology
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib. The company derives its revenue from United Kingdoms.